CBD /

 

Search

Custom query TAKE SEARCH TOUR
Search Clear
  • Sort
  • Export


Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Commercial Release (Import and Commercialization) Poulvac® Procerta HVT-IBD - Technical Opinion 7666/2021.
  • Country's Decision or any other Communication
  • bch-dec-br-299613-1
  • 25 Jun 2026
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Risk assessment Poulvac® Procerta HVT-IBD - Technical Opinion 7666/2021.
  • Risk Assessment generated by a regulatory process
  • bch-ra-br-299521-1
  • 16 Jun 2026
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
VAXXITEK® HVT+ IBD
  • Living Modified Organism
  • bch-lmo-scbd-109735-1
  • 25 Feb 2016
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Resolución 2399: Por la cual se autoriza el uso ( importación y comercialización) a la empresa Vetiplus S.A. de la vacuna aviar recombinante para inmunización activa contra la enfermedad de Marek (MD) y la enfermedad de Gumboro (IBD).
  • Country's Decision or any other Communication
  • bch-dec-co-105616-1
  • 12 Jun 2014
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Uso de la vacuna aviar recombinante para inmunización activa contra la enfermedad de Marek (MD) y la enfermedad de Gumboro (1BD)
  • Risk Assessment generated by a regulatory process
  • bch-ra-co-105615-1
  • 12 Jun 2014
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Resolución 2400: Por la cual se autoriza el uso (importación y comercialización) a la empresa Vetiplus S.A. de la vacuna aviar recombinante para inmunización activa contra la enfermedad de Marek (MD) y la enfermedad de Newcsatle) (ND)
  • Country's Decision or any other Communication
  • bch-dec-co-105618-1
  • 12 Jun 2014
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Uso de la vacuna aviar recombinante para inmunización activa contra la enfermedad de Marek (MD) y la enfermedad de Newcastle (ND)
  • Risk Assessment generated by a regulatory process
  • bch-ra-co-105617-1
  • 12 Jun 2014
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Commercial release of Genetically Modified Organism to be used as an Avian Vaccine - VECTORMUNE® HVT-IBD - Live frozen vaccine against Marek's Disease and Gumboro Disease
  • Country's Decision or any other Communication
  • bch-dec-br-105280-1
  • 28 Jan 2014
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Risk assessment of Genetically Modified Organism to be used as an Avian Vaccine - VECTORMUNE® HVT-IBD - Live frozen vaccine against Marek's Disease and Gumboro Disease
  • Risk Assessment generated by a regulatory process
  • bch-ra-br-105279-1
  • 28 Jan 2014
Please wait for the query to finish before exporting.

Quick links

About the BCH About the Cartagena Protocol Supplementary Protocol

Sign in Search records Submit records
Registries: LMO-Organism-Gene Country Profiles
National Report Analyzer

Forums BCH Announcements

Need help?

Knowledge Base FAQs UNEP eLearning Training Site

Contact us at: bch@cbd.int
BCH Biosafety Clearing-House
Subscribe to e-mail notifications
Subscribe to our newsletter